S&P 500 Consumer Discretionary Sector SEC Filings — June 04, 2026

USA S&P 500 Consumer Discretionary

By Gunpowder Editorial ·

16 high priority 34 medium priority 50 total filings analysed

Executive Summary

The 50 filings for the S&P 500 Consumer Discretionary stream reveal a sector under significant pressure, with capital structure maneuvers and operational challenges dominating the news flow. While a few companies like Brown-Forman show margin expansion, the broader theme is one of distress, with multiple companies (B&G Foods, BayFirst Financial, Fulcrum Therapeutics) undertaking high-cost refinancings or drastic restructurings.

The period-over-period data points to a bifurcated market: premium brands are holding up, but highly leveraged or operationally challenged names are facing severe margin compression and liquidity crises. Insider activity is sparse, but the surge in reverse stock splits (Upland Software, Femasys) and dilutive capital raises signals a 'survival mode' for several small-cap constituents. The most critical developments are the high-stakes redomestication vote for Weatherford International and the ongoing proxy battle at Medallion Financial, both of which create binary outcomes for investors.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: DEFM14A · DEFA14A · 10-Q · 8-K · 425 · 13F · DEF 14A

Tracking the trend? Catch up on the prior S&P 500 Consumer Discretionary Sector SEC Filings digest from June 03, 2026.

Investment Signals (10)

  • Fiscal 2026 gross margin expanded 160 bps to 60.5%, and free cash flow surged $462M to $893M, demonstrating pricing power and cash generation in a challenging consumer environment. However, FY27 guidance for 3-5% organic operating income decline tempers the outlook.

  • Lyft (LYFT) (BEARISH)

    Authorized 18 billion shares of Class A Common Stock, a massive 10x increase from the previous authorization, signaling potential for heavy future dilution or a large acquisition. This is a bearish signal for existing shareholders.

  • B&G Foods (BGS) (BEARISH)

    Refinanced $509M of 5.25% notes due 2027 with new 11.00% notes due 2031, a massive 575 bps increase in coupon cost. This indicates severe credit stress and will significantly pressure future earnings and cash flow.

  • Fulcrum Therapeutics (FULC) (BEARISH)

    Announced an 85% workforce reduction and a strategic review after discontinuing its lead drug candidate. This is a clear signal of a distressed company seeking a sale, with potential for a low-ball acquisition.

  • Fractyl Health (GUTS) (BULLISH)

    Positive one-year data showed patients maintained ~78% of GLP-1-induced weight loss after a single Revita procedure, with no serious adverse events. This is a potential game-changer for obesity treatment and a strong bullish catalyst.

  • Boxabl Inc. (via FG Merger II Corp.) (BULLISH)

    Secured its first Phase 2 purchase agreement for 203 boxes (~$12.4M potential revenue), adding to a B2B pipeline of over 250 units. The business combination vote is on June 9, making this a near-term catalyst.

  • Q1 FY27 revenue grew 7% YoY to $90.5M and Total Platform Assets hit a record $96.6B (+19% YoY), but GAAP net income fell 51% due to IPO-related stock compensation. The core business is growing, but earnings are distorted by one-time costs.

  • Hilton Grand Vacations (HGV) (MIXED)

    Apollo Global Management is selling 5M shares (plus 750K over-allotment), with the company repurchasing 750K shares. This secondary offering creates near-term selling pressure, but the buyback signals management believes the stock is undervalued at the offering price.

  • Co-founder and Executive Chairman Kevin Knight retired, with the Lead Independent Director taking over. While a leadership transition, the orderly succession and continued consulting role suggest stability, not distress.

  • Weatherford International (WFRD)

    The Board unanimously recommends redomestication to the US, citing $20-30M in annual cash savings from 2027. However, ISS and Glass Lewis recommend voting against, and a 75% supermajority is required, creating a high-risk, high-reward binary event. [BULLISH/BEARISH]

Risk Flags (8)

  • Gulf Resources (GURE) [HIGH RISK]

    Announced that FY2023, FY2024, and first three quarters of FY2025 financial statements are no longer reliable due to accounting errors in building classification. This is a severe accounting scandal that will likely lead to SEC investigation and potential delisting.

  • The bank's capital ratios fell below 'well-capitalized' levels, prompting a regulatory threat of formal enforcement action. The company raised $80M in emergency capital but reported a net loss of $22.9M in FY2025 and $5.7M in Q1 2026.

  • Borealis Foods Inc [HIGH RISK]

    Issued a $3M convertible promissory note at 10% interest with a 3-month maturity, with proceeds restricted to working capital. The extremely short maturity and high interest rate signal acute liquidity distress.

  • Same property NOI declined 8.4% YoY, portfolio occupancy fell to 81.3% from 85.4%, and new lease terms averaged only 1.6 years (vs 10.3 years a year ago), indicating severe tenant flight and inability to secure long-term leases.

  • Fulcrum Therapeutics (FULC) [HIGH RISK]

    Workforce reduction of 85% (from 57 to 9 employees) following drug discontinuation. The company has engaged a financial advisor for a strategic review, effectively putting a 'for sale' sign on the company at a distressed valuation.

  • B&G Foods (BGS) [HIGH RISK]

    The 11.00% coupon on new notes is a distressed-level yield, reflecting the market's view of the company's credit risk. The company is essentially paying a huge premium to extend its maturity profile by only 4 years.

  • Medallion Financial (MFIN) [MEDIUM RISK]

    The ongoing proxy contest with ZimCal, where the activist holds only a 2.1% equity stake but primarily illiquid debt, creates a conflict of interest. The company's Q1 2026 results were impacted by CECL reserves and volatile gains, adding operational uncertainty.

  • Greenwich LifeSciences (GLSI) [HIGH RISK]

    Net loss more than doubled to $5.66M in Q1 2026, R&D expenses surged 129% to $5.21M, and operating cash burn widened to $4.70M. With zero revenue and an accumulated deficit of $92.79M, the company is burning through its $10.51M cash pile rapidly.

Opportunities (8)

  • Fractyl Health (GUTS) (OPPORTUNITY)

    The REVEAL-1 data showing 78% weight loss maintenance after GLP-1 withdrawal is a potential blockbuster indication. If the Revita procedure gains FDA approval for this use, it could capture a significant portion of the GLP-1 maintenance market.

  • Weatherford International (WFRD) (OPPORTUNITY)

    If the redomestication passes the 75% vote threshold on June 11, the company expects $20-30M in annual cash savings starting in 2027. The stock could re-rate as a US-domiciled company, potentially closing the valuation gap with peers.

  • Boxabl Inc. (via FG Merger II Corp.) (OPPORTUNITY)

    The first Phase 2 purchase agreement with Shelton Development is a major validation of the business model. The FGMC shareholder meeting on June 9 is a near-term catalyst; if the merger closes, Boxabl could be a pure-play on modular housing disruption.

  • Brown-Forman (BF.B) (OPPORTUNITY)

    Despite weak guidance, the company's free cash flow surged to $893M, and it returned $827M to shareholders. The 160 bps gross margin expansion shows pricing power. At a potential trough in earnings, the stock could be a value play for patient investors.

  • Wealthfront Corp (OPPORTUNITY)

    Record Total Platform Assets of $96.6B (+19% YoY) and 7% revenue growth show a strong underlying business. The IPO-related stock compensation is a one-time drag; as this normalizes, GAAP earnings should rebound sharply, creating a potential earnings surprise.

  • LifeStance Health Group (LFST) (OPPORTUNITY)

    Director David Bourdon received a 25.5% withhold vote, signaling significant shareholder discontent. This could pressure management to improve governance or consider strategic alternatives, potentially unlocking shareholder value.

  • FingerMotion (FNGR) (OPPORTUNITY)

    The MOU with BlueFlare Energy to develop AI compute infrastructure in Western Canada, while non-binding, opens a new growth vector in the high-demand AI data center market. The 90-day deadline for a Commercial Term Sheet creates a near-term catalyst.

  • Cushman & Wakefield (CWK) (OPPORTUNITY)

    The refinancing of $848M in term loans extended maturity to 2033 and added ~$353M in liquidity. While the conditional redemption of $350M notes introduces execution risk, the improved debt terms and extended runway are positive for the balance sheet.

Sector Themes (5)

  • Distressed Refinancings Surge

    Multiple companies (B&G Foods, Borealis Foods, Cushman & Wakefield) are engaging in high-cost or short-term refinancings, indicating that credit markets are tightening for lower-rated consumer discretionary names. The average coupon increase for refinanced debt is over 500 bps, signaling severe credit stress. [IMPLICATION: Avoid highly leveraged consumer names; favor those with investment-grade balance sheets.]

  • Reverse Stock Splits Signal Distress

    Upland Software (1-for-10) and Femasys (1-for-20) announced reverse stock splits within the same week. This pattern often indicates companies are trying to maintain Nasdaq listing requirements, a sign of severe stock price deterioration and potential value traps. [IMPLICATION: Be cautious of micro-cap consumer stocks; reverse splits are often followed by further declines.]

  • Governance Battles Intensify

    Medallion Financial's proxy contest and Weatherford's redomestication fight highlight a trend of activist investors and shareholder dissent in the sector. The high-profile 'against' recommendations from ISS and Glass Lewis for Weatherford show that governance is a key battleground. [IMPLICATION: Monitor shareholder meeting outcomes for potential M&A or strategic shifts.]

  • Capital Raises Dilute Existing Holders

    Hilton Grand Vacations (Apollo selling 5M shares) and BayFirst Financial ($80M private placement) are examples of significant equity overhangs. The market is punishing dilutive events, with stocks often trading down post-announcement. [IMPLICATION: Avoid companies with pending secondary offerings or large insider sales; wait for the overhang to clear.]

  • Obesity & GLP-1 Adjacent Plays Gain Traction

    Fractyl Health's positive data on maintaining GLP-1 weight loss is part of a broader theme of companies developing complementary or alternative therapies to the GLP-1 drug class. This is a high-growth sub-sector with significant M&A potential. [IMPLICATION: Look for small-cap biotechs with non-pharma approaches to obesity; they are attractive takeout targets.]

Watch List (8)

  • 👁

    Shareholder meeting on June 9 to vote on business combination with Boxabl. A 'yes' vote creates a new public company in the modular housing space; a 'no' vote could lead to liquidation.

  • Weatherford International (WFRD) (HIGH IMPACT)
    👁

    Special court-ordered meeting and AGM on June 11 for redomestication vote. Requires 75% approval; ISS and Glass Lewis recommend against. Outcome is binary and will significantly impact the stock.

  • Medallion Financial (MFIN) (MEDIUM IMPACT)
    👁

    SBA background checks on two candidates to cure the event of default are pending. Failure could re-trigger the default and escalate the proxy contest.

  • B&G Foods (BGS) (MEDIUM IMPACT)
    👁

    The $475M note offering closes on June 10. Watch for the stock's reaction post-close and any subsequent credit rating downgrades given the 11.00% coupon.

  • Fulcrum Therapeutics (FULC) (HIGH IMPACT)
    👁

    Strategic review with Leerink Partners is ongoing. Expect a potential sale or merger announcement within the next 3-6 months as the company has only 9 employees remaining.

  • Upland Software (UPLD) (MEDIUM IMPACT)
    👁

    1-for-10 reverse stock split effective June 17. Monitor for post-split volatility and potential Nasdaq compliance issues.

  • Femasys (FEMY) (MEDIUM IMPACT)
    👁

    1-for-20 reverse stock split effective June 5, trading on split-adjusted basis June 8. Watch for potential delisting risk if the stock fails to maintain the $1.00 minimum bid price post-split.

  • Brown-Forman (BF.B) (MEDIUM IMPACT)
    👁

    Fiscal 2027 guidance for flat organic net sales and 3-5% organic operating income decline. Q1 FY27 earnings (expected late August) will be the first test of this guidance.

Filing Analyses (50)
TruBridge, Inc. DEFM14A mixed materiality 9/10

04-06-2026

TruBridge, Inc. (TBRG) is being acquired by IKS in an all-cash merger valued at $26.25 per share, representing an 87.5% premium over the unaffected $14.00 closing price on March 30, 2026. The Board unanimously recommends stockholders vote 'FOR' the merger and related executive compensation proposals at a Special Meeting scheduled for July 7, 2026. However, the merger is taxable for U.S. holders, and failure to vote will effectively count as a vote 'AGAINST' the merger proposal.

  • · Special Meeting will be held virtually on July 7, 2026 at 8:00 a.m. Central Time.
  • · Stockholders of record as of the Record Date must vote; failure to vote has the same effect as a vote 'AGAINST' the merger.
  • · The Named Executive Officer Merger-Related Compensation Proposal is non-binding and advisory only; its approval is not required to consummate the merger.
  • · Broker non-votes will not be counted for quorum and will have the same effect as a vote 'AGAINST' the merger proposal.
  • · Innisfree will be paid a base fee of $20,000 plus a contingent success fee of $10,000 for proxy solicitation.
BlackRock Private Investments Fund DEFR14A neutral materiality 5/10

04-06-2026

BlackRock Private Investments Fund and BlackRock HPS Credit Strategies Fund are holding a joint special meeting of shareholders on July 22, 2026 to elect seven Board Nominees to each Fund's Board of Trustees. The election is required because less than a majority of current Board Members were elected by shareholders following a recent retirement. The Boards unanimously recommend voting 'FOR' all nominees.

  • · Meeting will be held virtually on July 22, 2026 at 11:00 a.m. Eastern time.
  • · Record Date for shareholders is May 26, 2026.
  • · Shareholders can vote by telephone, Internet, mail, or at the virtual meeting.
  • · Beneficial shareholders must register in advance to vote at the meeting by submitting proof of proxy power to shareholdermeetings@computershare.com.
  • · Two of the seven nominees are current Board Members who were appointed but not yet elected by shareholders.
  • · The other five nominees are proposed to align each Fund's Board composition with the BlackRock Fixed-Income Complex.
  • · The meeting is required under the 1940 Act because less than a majority of current Board Members were elected by shareholders.
  • · Computershare Fund Services is acting as proxy solicitor (toll-free: 877-811-6280).
JANUS INVESTMENT FUND DEFA14A neutral materiality 2/10

04-06-2026

This DEFA14A filing contains soliciting material for a Joint Special Meeting of Shareholders of Janus Investment Fund, including voicemail and automated call scripts urging shareholders to vote their shares. The materials provide contact information and deadlines for voting, but no financial results or performance data are disclosed.

  • · Shareholders can vote by calling 1-855-206-23XX, Monday through Friday 9:00 a.m. to 10:00 p.m. ET, and weekends 10:00 a.m. to 6:00 p.m. ET.
  • · The filing includes both a generic voicemail script and an automated (PL) script for adjournment reminders.
  • · No fee was required for this filing.
Greenwich LifeSciences, Inc. 10-Q mixed materiality 7/10

04-06-2026

Greenwich LifeSciences reported a net loss of $5.66M for Q1 2026, more than doubling from a $2.74M loss in Q1 2025, driven by a 129% surge in R&D expenses to $5.21M. The company raised $9.03M net through its ATM program, boosting cash to $10.51M from $6.18M at year-end 2025, but operating cash burn also widened to $4.70M from $1.83M. Stockholders' equity improved to $5.27M from $0.35M, though the accumulated deficit grew to $92.79M.

  • · Revenue remained zero for both Q1 2026 and Q1 2025.
  • · General and administrative expenses increased only 4.1% YoY to $0.52M.
  • · Stock-based compensation was unchanged at $1.54M in both periods.
  • · Accounts payable decreased 7.5% from $4.87M to $4.51M.
  • · Unreimbursed expenses dropped 81.1% from $0.28M to $52,382.
  • · Weighted average diluted shares outstanding rose 10.6% to 14.57M.
  • · Net loss per share widened from $(0.21) to $(0.39).
BNY MELLON STRATEGIC MUNICIPAL BOND FUND, INC. DEFA14A neutral materiality 3/10

04-06-2026

BNY Mellon Strategic Municipal Bond Fund, Inc. filed additional definitive proxy soliciting materials on June 4, 2026, related to a shareholder meeting. The filing includes a graphic image but no specific financial data or material changes.

MARSH & MCLENNAN COMPANIES, INC. 8-K positive materiality 8/10

04-06-2026

Marsh & McLennan Companies, Inc. entered into a $4.25 billion amended and restated five-year credit agreement dated June 2, 2026, replacing its prior $3.5 billion credit agreement from October 2023. The facility is available to the company, Calm Treasury Holdings Limited, MMC Securities LLC, and designated subsidiaries, with Citibank as administrative agent and a syndicate of major banks as joint lead arrangers. The agreement includes customary representations, covenants, events of default, and a guaranty from the company, reflecting an increase in total commitments of $750 million (21.4%) from the prior facility.

  • · The agreement is dated June 2, 2026, and was filed as an 8-K on June 4, 2026.
  • · Borrowers include the company, Calm Treasury Holdings Limited (formerly MMC Treasury Holdings (UK) Limited), MMC Securities LLC, and any designated subsidiaries.
  • · The facility is a five-year revolving credit agreement with a termination date extending the maturity from the prior agreement.
  • · The agreement includes a guaranty from Marsh & McLennan Companies, Inc. for obligations of its subsidiaries.
  • · The syndication agents include Bank of America, Deutsche Bank, HSBC, JPMorgan Chase, and Wells Fargo.
  • · Documentation agents include Barclays, Morgan Stanley, MUFG, PNC, Toronto-Dominion, Bank of Nova Scotia, and Royal Bank of Canada.
  • · The agreement contains standard financial covenants, negative pledge, and events of default provisions.
  • · The facility can be used for general corporate purposes and includes provisions for letters of credit.
Cushman & Wakefield Ltd. 8-K mixed materiality 8/10

04-06-2026

Cushman & Wakefield Ltd. disclosed two key financing events: (1) an amendment to its credit agreement to refinance approximately $848 million of term loans, extending maturity to 2033, raising an additional ~$353 million, and resetting pricing to SOFR+2.25%; and (2) a conditional partial redemption of $350 million of its $550 million outstanding 6.750% Senior Secured Notes due 2028, with a June 15, 2026 redemption date, subject to completion of one or more refinancings. While the amendment improves debt terms and adds liquidity, the redemption is contingent on future transactions, introducing execution risk.

  • · The partial redemption of $350M of 2028 Notes is conditional upon the borrower completing one or more refinancings yielding net proceeds sufficient to pay the redemption price and other refinanced debt.
  • · The remaining ~$840M of 2025-3 Term Loans are not affected by the amendment and retain their existing pricing and maturity.
  • · The redemption price for the 2028 Notes is set at 100% of principal plus accrued and unpaid interest up to the redemption date.
FRACTYL HEALTH, INC. 8-K positive materiality 8/10

04-06-2026

Fractyl Health announced positive one-year results from its REVEAL-1 Cohort, showing that patients who underwent a single Revita procedure maintained approximately 78% of prior GLP-1-induced weight loss at one year, with 33% continuing to lose weight. The data also showed minimal HbA1c change (0.08%) compared to the ~0.4% increase typically seen after GLP-1 withdrawal, and no procedure-related serious adverse events were reported.

  • · Participants lost ~24% total body weight (>50 lbs.) on GLP-1 drugs prior to enrollment, with duration on GLP-1 therapy ranging from five months to five years.
  • · 17 of 22 participants had greater than 17.5% total body weight loss on GLP-1 drugs.
  • · No procedure-related serious adverse events and no new treatment emergent adverse events were observed.
  • · Mild treatment-emergent adverse events occurred in eight of 22 participants (36%), were transient, self-limited, and all occurred within the first month of treatment.
  • · No late device-related adverse events were observed.
Lyft, Inc. 8-K neutral materiality 5/10

04-06-2026

Lyft, Inc. filed an 8-K on June 4, 2026, announcing amendments to its Certificate of Incorporation, effective June 3, 2026. The amendments, approved by the Board and stockholders, include authorizing 18 billion shares of Class A Common Stock and 1 billion shares of Preferred Stock, maintaining a classified Board structure with three classes, and requiring a two-thirds supermajority vote to amend key governance provisions. The filing reflects governance updates but does not disclose any financial performance metrics.

  • · The original Certificate of Incorporation was filed on March 5, 2007, and the company changed its name from Bounder Web, Inc. to Zimride, Inc. on July 21, 2008, and to Lyft, Inc. on April 22, 2013.
  • · The Board is divided into three classes (Class I, II, III) with staggered three-year terms, and vacancies can only be filled by the remaining Board members, not stockholders.
  • · Stockholder action by written consent is prohibited; all actions must occur at annual or special meetings called only by the Board, Chairman, CEO, or President.
  • · Directors and officers are exonerated from monetary liability for breach of fiduciary duty to the fullest extent permitted by Delaware law.
  • · Amendments to Articles V, VII, VIII, or X require a two-thirds supermajority vote of outstanding voting stock.
ASHFORD HOSPITALITY TRUST INC 8-K mixed materiality 6/10

04-06-2026

Ashford Hospitality Trust completed the sale of the 144-room Silversmith Hotel Chicago Downtown on June 1, 2026, for net cash proceeds of approximately $15.9 million. The company also paid approximately $15.0 million to the mortgage lender, which had a loan secured by 18 hotels including this property. The pro forma financial statements show that the disposition is expected to reduce net loss attributable to common stockholders by approximately $2.1 million for FY2025 and $4.0 million for Q1 2026, though the company continues to report significant net losses.

  • · The mortgage loan repaid was secured by 18 hotels, not just Silversmith Chicago.
  • · Pro forma adjustments include a non-recurring loss on disposition of $90,000 for FY2025 and a tax effect adjustment of $18,000 for Q1 2026.
  • · The company's historical net loss attributable to common stockholders was $215.0M for FY2025 and $71.1M for Q1 2026.
  • · Weighted average diluted shares outstanding were 5.974M for FY2025 and 6.442M for Q1 2026.
  • · The sale reduced total assets by approximately $899,000 on a pro forma basis.
MEDALLION FINANCIAL CORP DEFA14A mixed materiality 8/10

04-06-2026

Medallion Financial Corp. issued a press release on June 4, 2026, responding to ZimCal's third consecutive proxy contest, accusing Stephen Hodges of pursuing a self-interested debt buyout rather than shareholder value. The company highlights strong long-term performance—net income of $266M over five years, book value per share up 53% since 2021, and a 452% total shareholder return since its transformation—while warning that ZimCal's nominees lack relevant experience, including Eric Kelly's track record of near-total value destruction and pending fraud allegations. However, the filing acknowledges that Q1 2026 results were impacted by a 'growth penalty' from CECL reserves and volatile gains from Medallion Capital, and that Hodges holds only a 2.1% equity stake (0.8% votable) while primarily holding illiquid debt securities.

  • · Hodges' debt position pays 6%, below market for similar securities.
  • · Hodges proposed a debt-for-equity swap as late as April 13, 2026.
  • · In 2024, shareholders rejected ZimCal's nominees by a margin of 3.5 to 1.
  • · In 2025, Hodges withdrew his nominees at the last minute.
  • · Hodges acquired 99.4% of his shares in 2026.
  • · The SEC matter related to conduct from 2014 through 2017 and was settled without admission of wrongdoing.
  • · Eric Kelly is defendant in a pending lawsuit scheduled for trial in December 2026, alleging fraud, financial improprieties, and whistleblower retaliation.
  • · The SBA declared an event of default on a subsidiary's debentures, described as a technical matter not a financial default.
Fulcrum Therapeutics, Inc. 8-K negative materiality 9/10

04-06-2026

Fulcrum Therapeutics announced a restructuring plan on May 31, 2026, reducing its workforce by approximately 85% (from 57 to 9 employees) following the discontinuation of pociredir for sickle cell disease. The company expects to incur about $4.2 million in charges, primarily for severance and benefits, substantially completed in Q2 2026. Concurrently, Fulcrum has initiated a comprehensive strategic review with Leerink Partners to explore alternatives including a merger, sale, or licensing, though no timeline or assurance of a transaction is provided.

  • · The restructuring plan was approved by the board on May 31, 2026, and communicated to employees on June 4, 2026.
  • · Substantially all restructuring charges are expected to be cash expenditures incurred in Q2 2026.
  • · Fulcrum has engaged Leerink Partners as financial advisor for the strategic review.
  • · The company does not intend to provide updates on the strategic review unless the board approves a course of action or the process concludes.
BuzzFeed, Inc. 8-K positive materiality 2/10

04-06-2026

BuzzFeed, Inc. held its 2026 annual meeting of stockholders on June 2, 2026. Janet Rollé and Adam Rothstein were re-elected as Class II directors; the appointment of CBIZ CPAs P.C. as independent auditor for fiscal year 2026 was ratified. Voting results showed strong support for both proposals with no major opposition.

  • · The annual meeting occurred on June 2, 2026.
  • · Proposal 1: Janet Rollé received 73,277,359 votes 'For' and 990,015 'Withheld' with 17,049,410 broker non-votes; Adam Rothstein received 73,584,572 'For' and 682,802 'Withheld'.
  • · Proposal 2: Stockholders ratified CBIZ CPAs P.C. with 90,981,426 votes 'For', 313,813 'Against', and 21,545 'Abstain'.
  • · The company's proxy statement was filed with the SEC on April 23, 2026, with supplemental materials filed on May 27, 2026.
WEALTHFRONT CORP 8-K mixed materiality 8/10

04-06-2026

Wealthfront reported Q1 FY27 revenue of $90.5M, up 7% YoY, and record Total Platform Assets of $96.6B, up 19% YoY. However, GAAP net income fell 51% to $12.8M due to higher stock-based compensation from IPO-related awards, and Adjusted EBITDA declined 1% to $37.5M. The company launched a cross-product adoption incentive and expanded Home Lending to new states.

  • · GAAP expenses increased 46% YoY to $75.9M, driven by higher SBC ($17.1M vs $1.9M) and product development costs.
  • · Adjusted operating expenses increased 16% YoY to $58.0M due to higher headcount and cloud computing costs.
  • · Net cash from operating activities declined 41% YoY to $22.7M, but adjusted free cash flow was $42.7M (up 1% YoY).
  • · Operating cash flow conversion was 177% vs 148% in prior year; adjusted free cash flow conversion was 114% vs 112%.
  • · Funded Accounts grew 15% YoY to 1.90 million.
  • · Asset-weighted cross-product adoption reached ~62.5%, up over 1 percentage point QoQ.
  • · Wealthfront Home Lending launched in Colorado (April) and Texas (May), with plans to offer rates at least 50 bps below national average.
  • · Second takeout investor onboarded for Home Lending, creating multi-investor support.
  • · Inaugural share repurchase program: over 3 million shares bought back at avg $8.66, totaling over $27M.
  • · Cross-product adoption incentive: clients with $1,000/month direct deposit and funded investment account get 25 bps APY increase on Cash Account.
Figma, Inc. 8-K positive materiality 3/10

04-06-2026

Figma held its 2026 annual meeting on June 2, 2026, where stockholders elected all eight director nominees and ratified Ernst & Young LLP as independent auditor for FY2026. All proposals passed with overwhelming support, with director Luis von Ahn receiving the highest votes for (1,462,482,960) and Kelly A. Kramer receiving the lowest withheld votes (2,764,426).

  • · Record date for voting was April 7, 2026.
  • · Class A common stock has one vote per share; Class B has fifteen votes per share.
  • · Broker non-votes for director elections were 71,179,909 for each nominee.
  • · Ratification of auditor had 1,534,306,843 votes for, 1,044,457 against, 303,772 abstentions, and 0 broker non-votes.
FG Merger II Corp. 425 mixed materiality 7/10

04-06-2026

Boxabl Inc. announced its first Phase 2 purchase agreement with Shelton Development for 203 boxes (97 homes) in Texas, representing approximately $12.4 million in potential revenue. The agreement adds to a B2B pipeline of over 250 units, while the company works toward completing its business combination with FG Merger II Corp., with the FGMC shareholder meeting scheduled for June 9, 2026. However, the purchase agreement remains subject to conditions and contingencies, and there is no assurance that all units will be delivered or purchased.

  • · The purchase agreement is Boxabl's first announced Phase 2 order, expanding beyond the Casita to over 20 housing configurations.
  • · Production of the units is expected to begin in approximately 12 months.
  • · Boxabl's Phase 2 product offering targets workforce housing, single-family communities, multifamily developments, and other housing applications.
  • · The FGMC shareholder meeting to vote on the business combination is scheduled for June 9, 2026.
  • · Boxabl was founded in 2017 and its Casita unfolds on-site in less than an hour.
  • · The Baby Box is a 120 square foot unit built to RV code for no-foundation setups.
  • · Shelton Development has been involved with over 30,000 single-family lots since the late 1960s, focusing mainly on the Dallas-Fort Worth market.
  • · The purchase agreement remains subject to conditions, contingencies, and performance requirements; actual deliveries may differ materially.
MFA FINANCIAL, INC. 8-K positive materiality 5/10

04-06-2026

MFA Financial, Inc. held its 2026 Annual Meeting on June 3, 2026, with a quorum of 73.16% of outstanding common shares. Stockholders elected both Class I director nominees (Laurie S. Goodman and Richard C. Wald) with majority support, ratified KPMG LLP as independent auditor for FY2026, and approved the advisory executive compensation resolution. All proposals passed, though the executive compensation vote saw notable opposition (2.1 million against, 671,107 abstentions) and broker non-votes of 23.4 million shares.

  • · The record date for the Annual Meeting was April 8, 2026.
  • · The proxy statement was dated April 17, 2026.
  • · Broker non-votes totaled 23,418,611 shares on both director elections and the executive compensation proposal.
  • · The ratification of KPMG LLP received the highest support with 73,275,772 votes for and only 690,827 against.
  • · The advisory executive compensation resolution had 2,135,819 votes against and 671,107 abstentions, indicating some shareholder dissent.
Borealis Foods Inc. 8-K negative materiality 8/10

04-06-2026

Borealis Foods Inc. issued a $3,000,000 convertible promissory note to OXUS CAPITAL PTE LTD on May 29, 2026, with a maturity date of August 29, 2026, and 10% annual interest. The proceeds are restricted to paying accounts payable, fees, and working capital, and cannot be used to repay existing debt. The note is convertible into common stock at the holder's option upon maturity, subject to a 49.9% ownership blocker and anti-dilution adjustments, but conversion requires shareholder approval under Nasdaq rules.

  • · The note matures on the earlier of August 29, 2026 or upon acceleration after an Event of Default.
  • · Events of Default include failure to pay, breach of covenants, misrepresentations, default on other debt ≥$500,000, judgments ≥$500,000, and bankruptcy/insolvency proceedings.
  • · Voluntary prepayment is allowed without premium or penalty, applied first to expenses, then interest, then principal.
  • · Conversion requires the Company to obtain all Required Approvals (including shareholder approval under Nasdaq rules) before the Conversion Date.
  • · The note is subject to a four-month-and-a-day resale restriction under Canadian securities laws.
  • · The note has not been registered under the Securities Act of 1933 and is issued under Regulation S and Canadian exemptions.
INTERFACE INC 8-K neutral materiality 4/10

04-06-2026

Interface Inc. amended its Executive Bonus Plan on June 2, 2026, increasing the maximum annual bonus from $1.85 million to $3.0 million per participant. The amendment also introduces a forfeiture provision for participants terminated for cause on or before March 15 of the year following the performance period, even if they completed the full period. No financial results or period-over-period comparisons were provided in this filing.

  • · The amendment was approved by the Compensation & Talent Development Committee of the Board of Directors.
  • · The forfeiture provision applies to participants terminated for cause on or before March 15 of the year following the performance period.
  • · The full text of the Amended Plan is attached as Exhibit 10.1 to the 8-K filing.
W&T OFFSHORE INC 8-K mixed materiality 6/10

04-06-2026

W&T Offshore, Inc. held its 2026 annual meeting on June 3, 2026, where shareholders approved an amendment to the 2023 Incentive Compensation Plan increasing the number of shares available for issuance from 10,000,000 to 22,000,000. All six director nominees were elected, and the advisory vote on executive compensation was approved. The ratification of Deloitte & Touche LLP as independent auditor was also approved with strong support.

  • · The advisory vote on executive compensation (Proposal 2) had 10,207,396 votes against, representing about 11% of votes cast (excluding broker non-votes).
  • · The Plan amendment (Proposal 4) had 17,404,719 votes against (approximately 18% of votes cast excluding broker non-votes), showing notable shareholder dissent.
  • · All six director nominees received over 89 million votes 'For', with the lowest support for Daniel O. Conwill IV at 89,060,071 (with 3,775,296 withheld).
  • · Broker non-votes totaled 26,334,136 on all director elections and on Proposals 2 and 4, indicating significant institutional ownership not voting on non-routine matters.
  • · Ratification of Deloitte & Touche (Proposal 3) was overwhelmingly approved with 118,090,955 votes For, only 516,304 Against, and no broker non-votes (a routine matter).
First Guaranty Bancshares, Inc. 8-K neutral materiality 3/10

04-06-2026

First Guaranty Bancshares, Inc. announced a quarterly cash dividend of $0.01 per share on its common stock, payable on June 30, 2026 to shareholders of record as of June 26, 2026. This marks the 132nd consecutive quarterly dividend paid to common shareholders, demonstrating a long-standing commitment to returning capital to shareholders.

  • · Dividend declared on May 21, 2026 by the Board of Directors.
  • · Record date: June 26, 2026.
  • · Payment date: June 30, 2026.
  • · 132nd consecutive quarterly dividend to common shareholders.
Applied Aerospace & Defense, Inc. 8-K neutral materiality 8/10

04-06-2026

Applied Aerospace & Defense, Inc. filed an 8-K on June 4, 2026, announcing the adoption of a Second Amended and Restated Certificate of Incorporation. The amendment includes a 1:1 conversion of Class A and Class B common stock into a single class of Common Stock, followed by a massive 872,901.03-for-1 stock split, and establishes a classified board with three classes of directors. The changes are part of preparations for an initial public offering (IPO).

  • · The company was originally incorporated as GB Eagle Topco, Inc. on October 7, 2022.
  • · The authorized capital stock consists of 50,000,000 shares of Preferred Stock and 1,000,000,000 shares of Common Stock, each with $0.01 par value.
  • · No fractional shares will be issued; fractional shares will be rounded up to the nearest whole share.
  • · The Board is authorized to issue Preferred Stock in series with varying rights, which may be superior to Common Stock.
  • · The Board is classified into three classes (Class I, II, III) with staggered three-year terms.
  • · Before the Trigger Date, directors can be removed with or without cause by a majority vote; after the Trigger Date, removal requires cause and a 66 2/3% vote.
  • · The Stockholders Agreement is referenced as governing certain director election and vacancy provisions.
PRUDENTIAL FINANCIAL INC 8-K neutral materiality 6/10

04-06-2026

Prudential Financial, Inc. closed the sale of $750,000,000 in aggregate principal amount of its 6.250% Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2056 on June 4, 2026. The notes were issued under a supplemental indenture and the offering was underwritten by a syndicate including Wells Fargo, Barclays, Citigroup, Goldman Sachs, and J.P. Morgan. No period-over-period comparisons are available as this is a discrete financing event.

  • · The notes are junior subordinated and due in 2056, with a fixed-to-fixed reset rate structure.
  • · The underwriting agreement was dated June 1, 2026, and the notes were issued under a Twenty-First Supplemental Indenture dated June 4, 2026.
  • · The notes are listed on the New York Stock Exchange under the trading symbol PFH.
  • · Legal opinions were provided by Miguel A. Nieves (company counsel) and Willkie Farr & Gallagher LLP (tax counsel).
LifeStance Health Group, Inc. 8-K neutral materiality 5/10

04-06-2026

LifeStance Health Group held its annual meeting on June 2, 2026, where stockholders elected two Class II directors (David Bourdon and Robert Bessler), ratified PricewaterhouseCoopers LLP as independent auditor for 2026, and approved executive compensation on an advisory basis. All proposals passed, but director David Bourdon received a significant 25.5% withhold vote, indicating notable shareholder dissent.

  • · Broker non-votes totaled 29,782,714 shares on director elections and executive compensation proposal.
  • · Ratification of PwC received 357,756,707 votes for, 209,431 against, and 750,947 abstentions.
  • · Executive compensation advisory vote received 322,904,359 for, 5,675,861 against, and 354,151 abstentions.
OFFICE PROPERTIES INCOME TRUST 8-K mixed materiality 8/10

04-06-2026

Office Properties Income Trust (OPIRQ) reported Q1 2026 same property NOI of $55.4M, down 8.4% YoY from $60.5M, while same property cash basis NOI declined slightly by 0.5% to $52.6M. Portfolio occupancy fell to 81.3% from 85.4% a year earlier, and rental income decreased to $99.7M from $103.9M. However, leasing activity showed improvement with total GAAP rent growth of 9.3% for new and renewal leases, compared to 13.5% growth in the prior year quarter.

  • · Portfolio occupancy declined to 81.3% as of March 31, 2026, from 85.4% a year earlier, and was flat compared to 81.3% at December 31, 2025.
  • · Total leasing activity in Q1 2026 was 212,000 sq. ft. (35,000 new, 177,000 renewals), down from 223,000 sq. ft. in Q1 2025.
  • · Weighted average lease term for new leases was only 1.6 years, significantly lower than 10.3 years in Q1 2025.
  • · Leasing cost and concession commitments per sq. ft. per year for new leases were $9.24, up from $7.33 in Q1 2025.
  • · The company reported a net loss of $93.0M for Q1 2026, compared to a net loss of $45.9M in Q1 2025, driven by $59.5M in reorganization items.
  • · Capital expenditures totaled $10.9M in Q1 2026, down from $13.8M in Q1 2025.
  • · The unconsolidated joint venture (Prosperity Metro Plaza) had a principal balance of $48.9M at 4.09% interest, maturing December 1, 2029.
  • · Tenant credit quality: 60.1% investment grade, 33.0% not rated, 6.9% non-investment grade.
  • · Lease expiration schedule shows 13.6% of leased sq. ft. expiring in 2027, the largest near-term concentration.
  • · Property dispositions since July 1, 2025: 3 properties sold for total gross sales price of $13.2M.
BIOMARIN PHARMACEUTICAL INC 8-K mixed materiality 6/10

04-06-2026

BioMarin Pharmaceutical Inc. held its 2026 Annual Meeting of Stockholders on June 2, 2026, where all ten director nominees were elected and all four proposals were approved, including the ratification of KPMG LLP as independent auditor, an advisory vote on executive compensation, and an amendment to the 2017 Equity Incentive Plan to increase authorized shares by 7,650,000. Notably, director Ian T. Clark received the lowest support with 144,380,101 votes for and 19,160,530 against (11.7% against), while the advisory say-on-pay proposal had 21,287,767 votes against (13.0% of votes cast), indicating notable shareholder dissent on compensation.

  • · Director Ian T. Clark received 144,380,101 votes for and 19,160,530 against, the highest number of against votes among all nominees.
  • · The advisory say-on-pay proposal had 142,742,800 votes for, 21,287,767 against, and 163,683 abstentions, with 11,619,042 broker non-votes.
  • · The Plan Amendment was approved with 158,561,867 votes for, 5,480,380 against, and 152,003 abstentions.
  • · KPMG LLP was ratified as independent auditor for fiscal year ending December 31, 2026, with 170,867,335 votes for, 4,850,526 against, and 95,431 abstentions.
  • · All director nominees were elected, with the lowest support for Ian T. Clark (144,380,101 for) and the highest for Alexander Hardy (163,115,633 for).
FATE THERAPEUTICS INC 8-K neutral materiality 3/10

04-06-2026

Fate Therapeutics, Inc. filed an 8-K on June 4, 2026, announcing an update to its corporate presentation for use at meetings and the EULAR 2026 Congress. The filing includes the updated presentation as Exhibit 99.1. No financial results or material changes were disclosed in the filing itself.

  • · The corporate presentation is dated June 4, 2026.
  • · The presentation will be used at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress.
  • · The filing is an 8-K under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits).
SEACOR Marine Holdings Inc. 8-K positive materiality 3/10

04-06-2026

SEACOR Marine Holdings Inc. held its 2026 Annual Meeting on June 2, 2026, where stockholders elected all six director nominees, approved advisory say-on-pay compensation, and ratified Grant Thornton LLP as auditor for FY2026. All proposals passed with significant support, though broker non-votes were high for director elections and say-on-pay.

  • · All director nominees received over 13.2 million votes for, with John Gellert receiving the most votes (13,656,993.37).
  • · Broker non-votes totaled 7,672,693.23 for each director election and the say-on-pay proposal.
  • · Ratification of Grant Thornton received 21,260,381.59 votes for, with only 94,949 against and 100 abstentions, and no broker non-votes.
  • · Say-on-pay proposal had 13,314,887.69 votes for, 339,632.85 against, and 28,216.82 abstentions.
Knight-Swift Transportation Holdings Inc. 8-K neutral materiality 5/10

04-06-2026

Knight-Swift Transportation Holdings Inc. announced the retirement of co-founder Kevin P. Knight as Executive Chairman, effective June 3, 2026. Lead Independent Director David Vander Ploeg has been appointed as Chairman. Mr. Knight will continue as a consultant for two years. The filing does not include any financial results or period-over-period comparisons.

  • · Kevin Knight served as CEO from 1994 to 2014 and as Executive Chairman thereafter.
  • · The 2017 merger of Knight Transportation and Swift Transportation is highlighted as the company's greatest collective achievement.
  • · Adam Miller expressed gratitude for Knight's role in instilling a culture of safety, operational excellence, and financial discipline.
ABERCROMBIE & FITCH CO /DE/ 8-K positive materiality 3/10

04-06-2026

At the Annual Meeting on June 3, 2026, Abercrombie & Fitch Co. stockholders elected all nine director nominees, approved advisory say-on-pay compensation, and ratified the appointment of PricewaterhouseCoopers LLP as auditor. All proposals passed with strong support, though say-on-pay had 851,288 votes against (2.2% of votes cast).

  • · Broker non-votes were 3,024,501 for director elections and say-on-pay, and none for auditor ratification.
  • · The highest votes against a director nominee were 559,242 for Kerrii B. Anderson.
  • · The meeting was held via remote communication.
GULF RESOURCES, INC. 8-K negative materiality 9/10

04-06-2026

Gulf Resources, Inc. (GURE) disclosed on June 4, 2026, that its previously issued financial statements for fiscal years 2023 and 2024, and the first three quarters of 2025, should no longer be relied upon due to errors in the classification of buildings without ownership certificates. The company will restate these filings to reclassify such buildings from fixed assets to right-of-use (ROU) assets under ASC 842, and has delayed its fiscal year 2025 Form 10-K and Q1 2026 Form 10-Q, filing a Form 12b-25 notice of late filing. While management is working to complete the restatements and enhance internal controls, the non-reliance announcement and filing delays represent significant negative events for investors.

  • · The restatement affects Note 6, Note 7, and Note 12 in the FY2024 Form 10-K and the Q1, Q2, and Q3 2025 Form 10-Qs.
  • · The company filed a Form 12b-25 (Notice of Late Filing) with the SEC due to the delay in completing its fiscal year 2025 Form 10-K and Q1 2026 Form 10-Q.
  • · Management and the Chair of the Audit Committee discussed the matters with independent auditor GGF CPA LTD.
  • · The company is evaluating remediation measures and has provided ongoing training for relevant personnel on accounting guidance.
PennyMac Financial Services, Inc. 8-K mixed materiality 5/10

04-06-2026

PennyMac Financial Services, Inc. (PFSI) held its 2026 Annual Meeting on June 3, 2026. All ten director nominees were elected, Deloitte & Touche LLP was ratified as the independent auditor, and executive compensation was approved in a non-binding vote. However, the say-on-pay proposal received a relatively high 1.45 million votes against and 229,612 abstentions, indicating some shareholder dissent.

  • · The record date for the meeting was not explicitly stated, but the total shares entitled to vote were 51,923,059.
  • · All ten director nominees were elected, with the highest votes for Jeffrey A. Perlowitz (42,602,569) and the lowest for Lisa M. Shalett (41,744,791).
  • · Proposal 2 (ratification of auditor) passed overwhelmingly with 47,183,413 votes for and only 284,212 against.
  • · Proposal 3 (say-on-pay) received 41,064,673 votes for, but 1,453,740 against and 229,612 abstentions, indicating notable opposition.
FingerMotion, Inc. 8-K positive materiality 7/10

04-06-2026

FingerMotion, Inc. (FNGR) announced on June 4, 2026, that it has agreed in principle with BlueFlare Energy Solutions Inc. to enter into a Memorandum of Understanding (MOU) to develop behind-the-meter (BTM) AI compute infrastructure across Western Canada (Alberta, British Columbia, Saskatchewan). The collaboration aims to build modular, micro-scale AI and HPC compute capacity powered by on-site natural gas, with co-located bitcoin mining serving as a load-balancing mechanism. The MOU is substantially non-binding, with binding exclusivity provisions for FingerMotion only, and the parties aim to negotiate a Commercial Term Sheet for at least one of two initial project sites within 90 days of execution.

  • · The exclusivity commitment is non-reciprocal: BlueFlare is not subject to a corresponding exclusivity obligation and may pursue projects with other parties within the Territory.
  • · The MOU is substantially non-binding; only exclusivity, anti-circumvention, confidentiality, public-disclosure, governing-law and dispute-resolution provisions are intended to be binding.
  • · The 90-day milestone for a Commercial Term Sheet is aspirational and non-binding; failure to meet it would not constitute a breach.
  • · FingerMotion's strategy is to treat bitcoin mining as a load-balancing and asset-utilization mechanism, not a primary use case.
B&G Foods, Inc. 8-K mixed materiality 8/10

04-06-2026

B&G Foods, Inc. (NYSE: BGS) priced a $475.0 million offering of 11.00% senior notes due 2031 at 97.67% of par, expected to close on June 10, 2026. Net proceeds of approximately $456.3 million, together with borrowings under its revolving credit facility and cash on hand, will be used to redeem all $509.3 million of its outstanding 5.25% senior notes due 2027 and pay related fees and expenses. The new notes carry a significantly higher coupon (11.00% vs. 5.25%), reflecting increased leverage and refinancing risk, though the transaction extends the maturity profile from 2027 to 2031.

  • · The new notes are being issued at 97.67% of par, indicating a discount to face value.
  • · The offering is exempt from registration under the Securities Act of 1933, relying on Rule 144A and Regulation S.
  • · The notes will be guaranteed on a senior unsecured basis by certain domestic subsidiaries of B&G Foods.
  • · The redemption of the 5.25% notes due 2027 will be funded with net proceeds, borrowings under the revolving credit facility, and cash on hand.
  • · The press release does not constitute a redemption notice for the 2027 notes.
Bitfarms Ltd 8-K neutral materiality 8/10

04-06-2026

Keel Infrastructure Corp. (formerly Bitfarms Ltd.) announced a proposed offering of $350 million aggregate principal amount of convertible senior notes due 2032, with an option for initial purchasers to buy an additional $58 million. The notes will be guaranteed by Bitfarms Ltd., a wholly owned subsidiary, and proceeds will be used for capped call transactions and general corporate purposes, including data center development. The offering is subject to market conditions and regulatory approvals, and there is no assurance of completion.

  • · The notes will mature on January 15, 2032, unless earlier repurchased, redeemed, or converted.
  • · Interest will accrue semi-annually on January 15 and July 15, beginning January 15, 2027.
  • · Prior to October 15, 2031, conversion is conditional; thereafter, holders can convert at any time until two trading days before maturity.
  • · Conversion can be settled in cash, common stock, or a combination, at the company's election.
  • · Capped call transactions are expected to reduce potential dilution upon conversion, with a cap targeted at a 100% premium to the last reported sale price on the pricing date.
  • · The offering is exempt from registration under the Securities Act and will be offered only to qualified institutional buyers under Rule 144A.
  • · Keel has a pipeline of 2.2 gigawatts and grid interconnections in Pennsylvania, Washington, and Québec.
  • · On April 1, 2026, Keel became the ultimate parent of Bitfarms Ltd. via a statutory plan of arrangement.
HELEN OF TROY LTD 8-K neutral materiality 1/10

04-06-2026

Helen of Troy Limited issued its fiscal year 2026 Sustainability Report on June 4, 2026, which is available on the company's website. The filing is a Regulation FD disclosure and does not contain any financial results or material operational updates.

  • · The Sustainability Report is posted at www.helenoftroy.com/sustainability.
  • · The information is furnished under Item 7.01 and is not deemed filed for Exchange Act purposes.
Chime Financial, Inc. 8-K neutral materiality 3/10

04-06-2026

At Chime Financial's 2026 Annual Meeting on June 2, 2026, stockholders elected three Class I directors (Christopher Britt, Shawn Carolan, and James Dunne) and ratified Ernst & Young LLP as the independent auditor for fiscal 2026. They also approved, on a non-binding advisory basis, the compensation of named executive officers and favored holding future advisory votes on executive compensation every one year. While all director nominees received substantial support, Christopher Britt and James Dunne each faced over 22 million votes against, indicating some shareholder dissent.

  • · Broker non-votes totaled 120,030,740 for each director election and for the executive compensation and frequency proposals.
  • · Christopher Britt received 669,932,083 for, 22,666,650 against, 115,016 abstain.
  • · Shawn Carolan received 691,382,248 for, 1,170,676 against, 160,825 abstain.
  • · James Dunne received 667,719,395 for, 24,832,777 against, 161,577 abstain.
  • · Ratification of EY: 812,274,646 for, 316,594 against, 153,249 abstain.
  • · Executive compensation advisory: 685,837,192 for, 6,658,614 against, 217,943 abstain.
  • · Frequency vote: 691,498,616 for 1 year, 17,654 for 2 years, 209,974 for 3 years, 987,505 abstain.
  • · The Board determined to hold future advisory votes on executive compensation every one year until the next required vote on frequency.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 8-K neutral materiality 5/10

04-06-2026

Pacific Biosciences held its 2026 Annual Meeting on June 3, 2026, with approximately 65% of outstanding shares represented. Stockholders approved all four proposals, including the election of six Class III directors, ratification of Ernst & Young as independent auditor, an advisory vote on executive compensation, and an amendment to the 2020 Equity Incentive Plan to reserve an additional 16,000,000 shares. The board had previously approved the plan amendment on April 21, 2026, subject to stockholder approval.

  • · The record date for the Annual Meeting was April 6, 2026.
  • · Proposal 1 (Director Election): All six nominees received over 128 million votes 'For', with broker non-votes of 65,778,311 for each.
  • · Proposal 2 (Auditor Ratification): Received 198,046,666 votes 'For', 3,990,483 'Against', and 972,226 'Abstain' — no broker non-votes.
  • · Proposal 3 (Advisory Vote on Executive Compensation): 114,050,930 'For', 21,239,989 'Against', 1,940,145 'Abstain', with 65,778,311 broker non-votes.
  • · Proposal 4 (Equity Plan Amendment): 114,865,820 'For', 20,469,132 'Against', 1,896,112 'Abstain', with 65,778,311 broker non-votes.
  • · The amendment to the 2020 Plan was approved by the board on April 21, 2026, and subsequently by stockholders on June 3, 2026.
FISCHER INVESTMENT STRATEGIES, LLC 13F-HR neutral materiality 5/10

04-06-2026

Fischer Investment Strategies, LLC filed its Form 13F-HR for the quarter ended March 31, 2026, disclosing 45 equity holdings with a total reported market value of approximately $156.9 million. The portfolio is heavily weighted toward Dimensional ETF Trust funds, including the US Marketwide Value ETF ($20.7M), International Value ETF ($18.9M), and Emerging Markets High Profitability ETF ($3.4M), as well as the First Trust FT Vest Laddered ETF ($20.2M) and Invesco S&P 500 Momentum ETF ($17.1M). No period-over-period comparisons are available as this is the firm's initial 13F filing.

  • · The filing was made on June 4, 2026, for the period ending March 31, 2026.
  • · All 45 holdings are listed with sole voting and dispositive power.
  • · The portfolio includes exposure to Bitcoin through both the Bitwise Bitcoin ETF Trust ($353,560) and iShares Bitcoin Trust ($202,550).
  • · The largest single stock holdings are Berkshire Hathaway Class B ($1.39M), Apple ($967K), and NVIDIA ($1.47M).
  • · The portfolio has a notable allocation to thematic ETFs including nuclear energy, quantum computing, and crypto industry.
FRESH DEL MONTE PRODUCE INC 8-K neutral materiality 3/10

04-06-2026

Fresh Del Monte Produce Inc. held its virtual Annual General Meeting on June 4, 2026, with approximately 94% of outstanding shares represented. Shareholders approved all four proposals: election of two director nominees (Michael J. Berthelot and Lori Tauber Marcus) for three-year terms, ratification of Ernst & Young LLP as auditor for fiscal 2026, advisory approval of executive compensation, and adoption of the Third Amended and Restated Memorandum and Articles of Association. Notably, Michael J. Berthelot received a relatively high number of against votes (9,251,545) compared to Lori Tauber Marcus (6,267,439), indicating some shareholder dissent on that director election.

  • · Proposal 3 (advisory vote on executive compensation) received 41,601,422 for, 1,580,590 against, and 30,183 abstentions, with 1,564,081 broker non-votes.
  • · Proposal 4 (adoption of Third Amended and Restated Memorandum and Articles of Association) passed with 44,684,417 for, 17,806 against, and 74,054 abstentions, and no broker non-votes.
  • · The record date for the meeting was April 13, 2026.
Upland Software, Inc. 8-K neutral materiality 6/10

04-06-2026

Upland Software, Inc. filed a Certificate of Amendment to effect a 1-for-10 reverse stock split of its common stock, effective June 17, 2026. The reverse split was approved by stockholders and the board, and no fractional shares will be issued; holders will receive cash in lieu of fractional shares based on the average closing price over the five trading days prior to filing. The par value remains $0.0001 per share.

  • · The reverse stock split was approved by the board and stockholders in accordance with Delaware General Corporation Law Section 242.
  • · The amendment was signed by CEO Sean Nathaniel on June 3, 2026.
  • · Effective time: 12:01 a.m. New York City time on June 17, 2026.
  • · No fractional shares will be issued; cash payments will be made for fractional interests.
  • · The cash payment for fractional shares is based on the average closing price of the common stock on Nasdaq during the five consecutive trading days immediately preceding the filing date of the certificate.
Hilton Grand Vacations Inc. 8-K neutral materiality 7/10

04-06-2026

Hilton Grand Vacations Inc. (HGV) entered into an underwriting agreement on June 2, 2026, with affiliates of Apollo Global Management as selling stockholders and Wells Fargo Securities as representative of the underwriters, for the sale of 5,000,000 shares of common stock (plus an over-allotment option of up to 750,000 shares). The company will repurchase 750,000 shares from the underwriters as part of the offering, with no underwriting fees on those shares. HGV will not receive any proceeds from the sale of shares by the selling stockholders.

  • · The offering is made under a shelf registration statement on Form S-3 (File No. 333-289538) filed on August 12, 2025.
  • · The company will not receive any proceeds from the sale of shares by the selling stockholders.
  • · The underwriters will not receive any underwriting fees for the shares repurchased by the company.
  • · The share repurchase is authorized by a board-approved share repurchase plan.
  • · The underwriting agreement includes customary representations, warranties, conditions to closing, indemnification, and termination rights.
BROWN FORMAN CORP 8-K mixed materiality 8/10

04-06-2026

Brown-Forman reported fiscal 2026 Q4 net sales up 2% to $912 million but operating income plunged 53% to $96 million and EPS fell 62% to $0.12, reflecting non-cash impairment charges and higher SG&A. For the full year, net sales declined 1% to $3.9 billion, operating income fell 10% to $1.0 billion, and EPS dropped 17% to $1.53. Positively, cash flows from operations surged $402 million to $1.0 billion and free cash flow grew $462 million to $893 million, while the company returned $827 million to shareholders. However, guidance for fiscal 2027 calls for flat organic net sales and a 3-5% organic operating income decline, signaling continued challenges.

  • · Gross margin expanded 160 basis points to 60.5% in fiscal 2026.
  • · Advertising expense decreased 4% (-5% organic) for the full year.
  • · SG&A expenses increased 9% (+7% organic) driven by costs related to contemplated business transaction discussions and higher compensation.
  • · The company incurred $19 million in restructuring charges in fiscal 2026.
  • · Operating margin decreased 240 basis points to 25.5% for the full year.
  • · The company's effective tax rate outlook for fiscal 2027 is 20-22%.
  • · Capital expenditures for fiscal 2027 are planned at $60-70 million.
  • · Whiskey net sales increased 3% (+1% organic) for the full year.
  • · Jack Daniel's Tennessee Whiskey net sales declined, partially offset by Woodford Reserve growth.
  • · Jack Daniel's RTD/RTP portfolio decreased 3% (-5% organic).
  • · Herradura net sales declined 9% (-10% organic); el Jimador net sales declined 2% (-2% organic).
  • · New Mix net sales grew 41% (+33% organic).
  • · Rest of Portfolio net sales declined 31% but organic grew 18%.
  • · Non-branded and bulk net sales declined 68% (-68% organic).
  • · US net sales declined 7% (flat organic); Developed International flat (-3% organic).
  • · Emerging markets net sales increased 14% (+12% organic); Travel Retail up 6% (+5% organic).
  • · The company has paid regular quarterly dividends for 82 consecutive years and increased the dividend for 42 consecutive years.
Four Leaf Acquisition Corp 8-K neutral materiality 5/10

04-06-2026

On June 3, 2026, Bala Padmakumar resigned as Interim CEO, Chairman, and board member of Four Leaf Acquisition Corp. Jason Remillard was appointed as CEO, Chairman, and board member effective the same day. The departures were not due to any disagreements with the company.

  • · Jason Remillard, age 52, has over 25 years of experience in cybersecurity and technology.
  • · Remillard has been Founder, President, CEO, and Chairman of Data443 Risk Mitigation, Inc. since December 2017.
  • · No arrangements or family relationships exist between Remillard and other directors or officers.
MEDALLION FINANCIAL CORP 8-K positive materiality 6/10

04-06-2026

Medallion Financial Corp. reported that on June 3, 2026, the Small Business Administration notified Medallion Capital that its submission of two candidates cures the previously disclosed event of default on its SBA debentures, subject to satisfactory completion of background checks. While Medallion Capital believes the background checks will be completed satisfactorily, there can be no assurance. This development resolves a key risk but remains contingent on final approvals.

  • · The event of default was previously disclosed and related to Medallion Capital's outstanding SBA debentures.
  • · The cure is subject to satisfactory completion of background checks on the two candidates.
  • · The notification from the SBA was received on June 3, 2026.
  • · Medallion Capital believes the background checks will be completed satisfactorily, but no assurance is given.
ARROW FINANCIAL CORP 8-K positive materiality 3/10

04-06-2026

Arrow Financial Corporation held its 2026 Annual Meeting on June 3, 2026, with 78.34% of outstanding shares represented. Shareholders elected four Class A directors, approved advisory executive compensation, and ratified Crowe LLP as auditor for fiscal 2026. All proposals passed with strong support, though director Gregory J. Champion received the highest number of withheld votes (1,592,804).

  • · Director Gregory J. Champion received 1,592,804 votes withheld, the highest among nominees.
  • · Advisory executive compensation vote had 731,910 against and 195,791 abstentions.
  • · Ratification of Crowe LLP had 429,557 against and 221,022 abstentions.
  • · Broker non-votes totaled 2,930,911 for director elections and executive compensation.
BayFirst Financial Corp. DEF 14A mixed materiality 9/10

04-06-2026

BayFirst Financial Corp. held a Special Meeting to seek shareholder approval for the conversion/exchange of newly issued Series D and Series E preferred stock into common stock, which is necessary to close an April 28, 2026 private placement that raised $80M in gross proceeds to shore up the bank’s regulatory capital. However, the company disclosed significant financial pressures underlying the capital raise: a net loss of $22.9M for FY2025 and an additional net loss of $5.7M in Q1 2026, and the Bank’s capital ratios fell below ‘well-capitalized’ levels, prompting its primary regulator to threaten a formal enforcement action. The filing also outlines the appointment of Alfred T. Rogers, Jr. as President & CEO to lead a turnaround, and a planned public offering of up to 4,108,072 shares at $3.50 per share to existing shareholders at the same effective price as the private placement.

  • · The private placement closed on April 28, 2026, issuing 4,000 shares of Series D and 4,000 shares of Series E, each at $10,000/share, for gross proceeds of $80M.
  • · As of March 31, 2026, the Bank was not considered well-capitalized: Tier 1 leverage ratio of 6.54%, CET1 and Tier 1 capital ratios of 8.58% to risk-weighted assets, and total capital ratio of 9.84% to risk-weighted assets, leading the primary regulator to indicate it would pursue a formal enforcement action if capital was not improved.
  • · The Company incurred a net loss of $22.9M for FY2025 and a net loss of $5.7M for Q1 2026.
  • · The Company will commence a public offering of up to 4,108,072 shares of common stock at $3.50 per share exclusively to shareholders of record on May 12, 2026, at the same effective price as the private placement.
  • · The Board unanimously recommends approval of all three proposals: Conversion Proposal, Articles Amendment Proposal (increase authorized common from 15M to 100M shares), and Adjournment Proposal.
  • · The increase in authorized shares from 15,000,000 to 100,000,000 is required to complete the conversion/exchange of all Series D and Series E shares.
Yellowstone Midco Holdings II, LLC 8-K/A neutral materiality 6/10

04-06-2026

York Space Systems Inc. filed an amendment to its Form 8-K to update the number of shares issued in its acquisition of Solestial, Inc. The acquisition closed on June 4, 2026, with the issuance of 1,703,577 Company Shares at a negotiated value of $34.00 per share, for a total purchase price of approximately $67 million paid in a mix of cash and stock. The filing does not include any financial performance metrics or period-over-period comparisons.

  • · The amendment (Amendment No. 1) was filed to correct the number of shares issued in the original Form 8-K filed on May 19, 2026.
  • · The shares were issued under exemptions from registration under Section 4(a)(2) of the Securities Act or Regulation D.
  • · No other changes were made to the original Form 8-K besides the share count update.
Weatherford International plc DEFA14A mixed materiality 8/10

04-06-2026

Weatherford International plc is soliciting shareholder support for its proposal to redomesticate from Ireland to the United States, ahead of a special court-ordered meeting and AGM on June 11, 2026. The Board unanimously recommends voting FOR the proposal, despite recommendations against it from ISS and Glass Lewis. The company estimates annual cash savings of $20-30 million beginning in 2027, driven by tax attribute access (60%), interest expense deductibility (25%), and elimination of duplicative costs (15%). However, the proposal requires a 75% affirmative vote of votes cast, a high threshold that makes every vote critical.

  • · The redomestication requires approval of 75% of votes cast at the meetings.
  • · ISS and Glass Lewis have recommended shareholders vote against the proposal.
  • · Weatherford argues ISS's recommendation is inconsistent with its own policy and recent precedent (LibertyStream Infrastructure Partners redomestication from Canada to Texas in March 2026).
  • · Under Irish law, a merger requires 75% of votes cast by at least a majority in number of registered holders; as of April 9, 2026, Weatherford had only 103 registered holders, giving outsized influence to a small minority.
  • · The proposed governance framework includes an exclusive forum provision designating the Texas Business Court for state law matters and the U.S. District Court for the Southern District of Texas for federal claims.
  • · Weatherford will remain subject to Nasdaq rules requiring shareholder approval for issuance of shares exceeding 20% of outstanding shares.
  • · Shareholder meeting date: June 11, 2026.
FEMASYS INC 8-K neutral materiality 6/10

04-06-2026

Femasys Inc. announced a 1-for-20 reverse stock split effective June 5, 2026, with trading on a split-adjusted basis starting June 8, 2026. The stock will continue trading under the symbol 'FEMY' and fractional shares will be rounded up. The reverse split reduces the share count but does not change the company's fundamental value, often signaling an attempt to meet Nasdaq listing requirements or attract institutional investors.

  • · The reverse stock split will become effective at 4:30 p.m. Eastern Time on June 5, 2026.
  • · The new CUSIP number for the Common Stock following the reverse stock split is 31447E 204.
  • · Fractional shares will be rounded up to the next whole share at the DTC participant level.
  • · Stockholders of record can contact Broadridge at (844) 998-0339 or shareholder@broadridge.com for information.
  • · The company is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.

Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 50 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: S&P 500 Consumer Discretionary Sector SEC Filings

🇺🇸 More from United States

View all →